Blocking a telomere protein in blood vessels did not slow glioblastoma in mice
Original title: Targeting telomeres in brain vasculature does not impede initiation and progression of glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in mice, and the approach did not work.
The short version
Researchers tried to slow brain tumor growth by targeting the blood vessels that feed it, and it did not work.
What was studied. This was a lab study using a mouse model of glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. The researchers removed a protein called TRF1, which protects the ends of chromosomes, from the cells that line blood vessels. They wanted to see if that would slow the tumor.
What they found. Removing TRF1 led to a trend toward fewer blood vessel cells in the tumors. There was also a trend toward more DNA damage in those vessel cells, which is what the researchers expected. But none of this slowed the tumor down. The tumors still started and grew the same way.
What this means, and what it doesn't
What it could mean: For now, this points researchers away from one idea. Targeting this protein in blood vessels alone does not appear to hold glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary back. Earlier work by the same group suggested that blocking TRF1 more broadly did slow tumor growth, so the tumor cells themselves may matter more than the vessels.
What it doesn't mean: This does not change any treatment you can get today. This was done in mice, not in people. No drug was tested in patients here. A negative result like this helps scientists rule out a path, but it is not a treatment, and it is not a promise of a cure.
Source: PubMed, August 12, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.